The combination of EPCAM/GAS2L1 surface protein stainings may increase the detection rate and comprehensiveness of CTC studies in pancreatic cancer without limiting the availability of the isolated CTCs for downstream analyses. The gene discussed is EPCAM; the disease is pancreatic neoplasm.